Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone dosing regimens in children with primary immune thrombocytopenia
ChiCTR2100053452Phase 4Recruiting
- Sponsor
- Huizhou Central People's Hospital
- Start
- Jan 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of prednisone in immune thrombocytopenia (ITP) (2 arms), sponsored by Huizhou Central People's Hospital. Primary endpoints: primary response rate and sustained response rate. Started Jan 2022; status: recruiting.
02
Drugs
prednisone
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on ChiCTR2100053452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053452.